Yuimedi is a healthcare technology company that develops a medical data utilization platform. The company is headquartered in Chuo-ku, Tokyo and lists its representative director as グライムス英美里. On January 1, 2024 Yuimedi established a U.S. subsidiary, Yuimedi, Corp. The firm announced an additional fundraising of 400 million yen. The financing consisted of an equity round led by DG Daiwa Ventures and venture debt from あおぞら企業投資株式会社. No operating metrics were disclosed in the announcement.

Total raised

$2M

Funding rounds

2

Latest round

Equity

Latest activity

Jul 2024